IceCure Medical Ltd.(ICCM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ICCM IceCure Medical Ltd.

盘后交易 09-04 16:37:25 EDT

2.23

+0.03

+1.36%

盘后2.23

+0.000.00%

16:10 EDT

最高2.25	最低2.13	成交量5.84万
今开2.20	昨收2.20	日振幅5.23%
总市值764.08万	流通市值489.90万	总股本342.64万
成交额12.82万	换手率2.66%	流通股本219.69万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ICCM","market":"US","secType":"STK","nameCN":"IceCure Medical Ltd.","latestPrice":2.23,"timestamp":1788552000000,"preClose":2.2,"halted":0,"volume":58362,"hourTrading":{"tag":"盘后","latestPrice":2.23,"preClose":2.23,"latestTime":"16:10 EDT","volume":654,"amount":1478.4201702,"timestamp":1788552604212,"change":0,"changeRate":0,"amplitude":0.017937},"delay":0,"changeRate":0.013636363636363547,"floatShares":2196874,"shares":3426375,"eps":-6.659186,"marketStatus":"盘后交易","change":0.03,"latestTime":"09-04 16:37:25 EDT","open":2.2,"high":2.245,"low":2.13,"amount":128199,"amplitude":0.052273,"askPrice":2.35,"askSize":17,"bidPrice":2.14,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-6.659186,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1788566400000},"marketStatusCode":4,"adr":0,"listingDate":1629950400000,"exchange":"NASDAQ","adjPreClose":2.2,"preHourTrading":{"tag":"盘前","latestPrice":2.22,"preClose":2.2,"latestTime":"09:28 EDT","volume":1987,"amount":4334.093280200001,"timestamp":1788528502014,"change":0.02,"changeRate":0.009091,"amplitude":0.018364},"postHourTrading":{"tag":"盘后","latestPrice":2.23,"preClose":2.23,"latestTime":"16:10 EDT","volume":654,"amount":1478.4201702,"timestamp":1788552604212,"change":0,"changeRate":0,"amplitude":0.017937},"volumeRatio":0.910754},"requestUrl":"/m/hq/s/ICCM","defaultTab":"news","newsList":[{"id":"1197502357","title":"Icecure与荷兰签署Prosense®冷冻消融系统独家分销协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1197502357","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197502357?lang=zh_cn&edition=full","pubTime":"2026-08-24 19:51","pubTimestamp":1787572274,"startTime":"0","endTime":"0","summary":"Icecure Medical Ltd.宣布，已就Prosense冷冻消融系统在荷兰市场达成一项独家分销协议。协议的核心，是授予合作方在荷兰境内独家推广与销售Prosense系统的权利。此举有望显著提升该创新疗法在荷兰的可及性，为当地患者带来新的治疗选择。通过这一合作，Icecure旨在深化其国际布局，并强化其在微创肿瘤治疗领域的市场地位。Icecure方面表示，相信凭借合作伙伴在当地深厚的网络与专业经验，能够有效推动Prosense技术的临床采纳与应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICCM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191866126","title":"West癌症中心获IRB批准，启动IceCure乳腺癌冷冻消融CHOICE研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1191866126","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191866126?lang=zh_cn&edition=full","pubTime":"2026-08-20 20:16","pubTimestamp":1787228202,"startTime":"0","endTime":"0","summary":"West癌症中心已获得机构审查委员会的正式批准，即将启动由IceCure Medical主导的CHOICE研究项目，该研究聚焦于乳腺癌冷冻消融技术的临床应用。CHOICE研究是一项前瞻性、多中心的临床试验，旨在评估IceCure Medical旗下ProSense系统在早期乳腺癌患者中的安全性与有效性。目前，CHOICE研究已在全球多个国家和地区同步开展，而West癌症中心作为美国南部地区的核心研究站点，其获批进展无疑为该研究注入了新的动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659192990","title":"奖金约700万元！湖北人袁新意获得国际大奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2659192990","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659192990?lang=zh_cn&edition=full","pubTime":"2026-08-14 11:07","pubTimestamp":1786676820,"startTime":"0","endTime":"0","summary":"据了解，未来科学大奖单项奖金100万美金。2020年1月，袁新意回到北大，任北京国际数学研究中心讲席教授。2026年1月，第十届世界华人数学家大会隆重开幕，袁新意获得“华人菲尔兹奖”的ICCM数学奖金奖。在7月23日的2026年国际数学家大会上，袁新意还受邀成为大会报告人，见证了校友王虹、邓煜获得菲尔兹奖。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-14/doc-ininhaiu2665553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179920158","title":"Icecure公布2026年上半年财报：营收同比劲增45%","url":"https://stock-news.laohu8.com/highlight/detail?id=1179920158","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179920158?lang=zh_cn&edition=full","pubTime":"2026-08-12 20:35","pubTimestamp":1786538148,"startTime":"0","endTime":"0","summary":"IceCure Medical Ltd. 近日披露了2026年上半年度财务报告。数据显示，该公司营收表现亮眼，与去年同期相比实现了45%的显著增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143378789","title":"Icecure Medical：Sio 提交请愿，要求 NCCN 将冷冻消融术纳入乳腺癌治疗指南，援引 Icecure 的 Prosense® 获 FDA 批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1143378789","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143378789?lang=zh_cn&edition=full","pubTime":"2026-07-29 20:28","pubTimestamp":1785328109,"startTime":"0","endTime":"0","summary":"Icecure Medical Ltd. 近日宣布，Sio 已正式向美国国家综合癌症网络（NCCN）提交请愿，恳请其将冷冻消融技术纳入乳腺癌治疗指南。此项动议的关键依据，正是 Icecure 旗下 Prosense® 系统已获得美国食品药品监督管理局（FDA）的上市许可。此举旨在推动这一微创疗法在乳腺癌治疗领域的更广泛应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653726710","title":"中国籍数学家实现菲尔兹奖突破！王虹、邓煜双双获奖，丘成桐：希望两人回国任教","url":"https://stock-news.laohu8.com/highlight/detail?id=2653726710","media":"红星新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653726710?lang=zh_cn&edition=full","pubTime":"2026-07-23 22:13","pubTimestamp":1784815980,"startTime":"0","endTime":"0","summary":"　　中国人在国际数学家大会一炮双响。7月23日，四年一度的菲尔兹奖在美国费城揭晓，王虹、邓煜两位中国籍数学家获奖。　　菲尔兹奖被称为“数学界的诺贝尔奖”，近百年间仅诞生两位女性获奖者，王虹成为第三位。1982年、2006年，丘成桐、陶哲轩两位华人数学家摘得菲奖，王虹、邓煜则实现中国籍获奖者突破。　　今年1月，王虹和邓煜已经共同获得了世界著名数学家、清华大学求真书院院长丘成桐发起的世界华人数学家大会的数学金奖。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2026-07-23/doc-iniivihw9344825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136410680","title":"IceCure强调Prosense™冷冻消融技术在巴西的商业应用扩展，此前FDA已批准其用于乳腺癌治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1136410680","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136410680?lang=zh_cn&edition=full","pubTime":"2026-07-06 20:15","pubTimestamp":1783340106,"startTime":"0","endTime":"0","summary":"IceCure Medical Ltd. 强调，在获得美国食品药品监督管理局（FDA）针对乳腺癌治疗的批准后，其Prosense™冷冻消融系统在巴西的商业应用正在持续扩展。这一进展标志着该创新医疗技术在国际市场，特别是巴西这一重要医疗市场中的接受度和商业化进程正稳步提升。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICCM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140033967","title":"IceCure Medical提交文件，拟注册出售股东转售至多550万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1140033967","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140033967?lang=zh_cn&edition=full","pubTime":"2026-06-26 04:33","pubTimestamp":1782419591,"startTime":"0","endTime":"0","summary":"IceCure Medical Ltd. 已向美国证券交易委员会提交文件，旨在为其一位出售股东注册并转售高达550万股普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICCM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168879232","title":"IceCure宣布以高于市价的价格完成550万美元定向增发，单一医疗健康领域机构投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=1168879232","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168879232?lang=zh_cn&edition=full","pubTime":"2026-06-18 01:16","pubTimestamp":1781716576,"startTime":"0","endTime":"0","summary":"IceCure Medical Ltd. (ICCM) 近日宣布，已与一家专注于医疗健康领域的机构投资者达成协议，完成了一轮总额550万美元的私募股权融资。此次定向增发的发行价格设定在高于当前市场交易价格的水平。\n这笔资金的注入将为公司推进其核心冷冻治疗技术的临床开发与商业化战略提供关键支持。通过引入单一的专业机构投资者，IceCure旨在强化其资产负债表，并加速其在微创肿瘤治疗领域的市场拓展步伐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICCM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143225521","title":"IceCure 公布其乳腺癌冷冻消融术在美国商业装机量在获 FDA 许可后激增 70%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143225521","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143225521?lang=zh_cn&edition=full","pubTime":"2026-06-17 20:25","pubTimestamp":1781699117,"startTime":"0","endTime":"0","summary":"在获得美国食品药品监督管理局的许可后，IceCure Medical Ltd. 的乳腺癌冷冻消融系统在美国的商业装机量实现了显著扩张。该公司报告称，其活跃的商业装机基数实现了高达 70% 的增长，这一数据凸显了市场对其创新疗法的强劲需求与快速接纳。这一增长标志着该技术在美国临床实践中的渗透率加速提升。公司业绩的这一积极进展，为其后续的市场拓展和商业化进程奠定了坚实基础。随着装机网络的扩大，IceCure 有望进一步巩固其在肿瘤微创介入治疗领域的市场地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158972323","title":"纳斯达克给予IceCure 180天宽限期，以满足最低股价要求","url":"https://stock-news.laohu8.com/highlight/detail?id=1158972323","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158972323?lang=zh_cn&edition=full","pubTime":"2026-05-14 06:46","pubTimestamp":1778712371,"startTime":"0","endTime":"0","summary":"IceCure Medical Ltd. 已获得纳斯达克交易所的批准，将额外获得180天的时间来恢复对其最低股价要求的合规性。该决定为这家医疗设备公司提供了更长的窗口期，以提升其股价至规定门槛以上。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126108165","title":"IceCure公布400万美元注册直接发行与同步私募配售定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1126108165","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126108165?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:02","pubTimestamp":1774526536,"startTime":"0","endTime":"0","summary":"IceCure Medical Ltd. (以下简称\"IceCure\")近日宣布，已完成一项总额400万美元的注册直接发行及同步私募配售的定价工作。此次融资旨在支持公司核心业务发展及技术创新。通过注册直接发行与私募配售相结合的方式，IceCure将灵活调配资金用途，进一步巩固其在医疗科技领域的市场地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICCM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142354633","title":"IceCure Medical Ltd.公布四年随访数据：≤3厘米肿瘤无复发率达89.4%，整体人群达83.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142354633","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142354633?lang=zh_cn&edition=full","pubTime":"2026-03-25 20:37","pubTimestamp":1774442247,"startTime":"0","endTime":"0","summary":"IceCure Medical Ltd.最新临床研究数据显示，其冷冻消融技术在四年随访期内展现出卓越的肿瘤控制效果。针对直径不超过3厘米的肿瘤患者群体，无复发存活率高达89.4%；而整体研究人群的无复发存活率同样表现强劲，达到83.9%。随着医学界对微创治疗需求的持续增长，这些长期随访数据为冷冻消融技术的临床应用提供了有力支撑。值得注意的是，83.9%的整体无复发率表明该技术具备广泛的适用性，为更多肿瘤患者提供了新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICCM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148583394","title":"IceCure公布肾癌冷冻消融研究五年积极顶线结果：无复发率达89.4%与83.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148583394","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148583394?lang=zh_cn&edition=full","pubTime":"2026-03-25 20:36","pubTimestamp":1774442167,"startTime":"0","endTime":"0","summary":"IceCure Medical Ltd. 近日发布了其针对肾脏肿瘤的冷冻消融疗法五年期研究的顶线结果，数据表现积极。研究显示，患者在接受治疗后，五年无复发率分别达到89.4%和83.9%，凸显了该疗法在肾癌治疗领域的潜在价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512895483","title":"Icecure Medical Ltd.盘中异动 股价大涨7.84%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512895483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512895483?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:33","pubTimestamp":1739975580,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时33分，Icecure Medical Ltd.股票出现波动，股价快速上涨7.84%。截至发稿，该股报1.65美元/股，成交量8.2374万股，换手率0.15%，振幅2.29%。Icecure Medical Ltd.股票所在的医疗器械行业中，整体涨幅为0.13%。其相关个股中，Sintx Technologies, Inc.、Reshape Lifesciences, Inc.、Penumbra, Inc.涨幅较大，Sintx Technologies, Inc.、Reshape Lifesciences, Inc.、Tivic Health Systems, Inc.较为活跃，换手率分别为2712.52%、298.20%、5.64%，振幅较大的相关个股有Sintx Technologies, Inc.、Tivic Health Systems, Inc.、Movano Inc.，振幅分别为17.37%、10.41%、6.65%。Icecure Medical Ltd.公司简介：Icecure Medical Ltd是一家商业化的医疗器械公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223301a24bf9e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223301a24bf9e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIVC","ICCM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512759166","title":"Icecure Medical Ltd.盘中异动 急速上涨5.15%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512759166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512759166?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:59","pubTimestamp":1739890773,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时59分，Icecure Medical Ltd.股票出现波动，股价快速拉升5.15%。截至发稿，该股报1.43美元/股，成交量17.3748万股，换手率0.31%，振幅3.31%。Icecure Medical Ltd.股票所在的医疗器械行业中，整体跌幅为0.82%。其相关个股中，Rapid Micro Biosystems, Inc.、Anteris Technologies Global Corp.、Pavmed Inc.涨幅较大，Reshape Lifesciences, Inc.、Allurion Technologies, Inc.、Tivic Health Systems, Inc.较为活跃，换手率分别为476.04%、16.94%、12.18%，振幅较大的相关个股有Cytosorbents Corporation、Outset Medical, Inc.、Pacific Biosciences Of California, Inc.，振幅分别为20.00%、14.04%、12.43%。Icecure Medical Ltd.公司简介：Icecure Medical Ltd是一家商业化的医疗器械公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225933a24ab2fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225933a24ab2fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380800","title":"Icecure Medical Ltd.盘中异动 早盘大幅拉升5.26%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510380800?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:40","pubTimestamp":1739284809,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时40分，Icecure Medical Ltd.股票出现波动，股价急速上涨5.26%。截至发稿，该股报1.37美元/股，成交量4.8422万股，换手率0.09%，振幅3.46%。Icecure Medical Ltd.股票所在的医疗器械行业中，整体跌幅为0.21%。其相关个股中，Lifeward Ltd.、Beyond Air, Inc.、Inspira Technologies Oxy B.H.N. Ltd.涨幅较大，Inspira Technologies Oxy B.H.N. Ltd.、Lifeward Ltd.、Beyond Air, Inc.较为活跃，换手率分别为56.10%、15.67%、2.64%，振幅较大的相关个股有Lifeward Ltd.、Hyperfine, Inc.、Beyond Air, Inc.，振幅分别为18.18%、16.77%、15.99%。Icecure Medical Ltd.公司简介：Icecure Medical Ltd是一家商业化的医疗器械公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112240099881beb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112240099881beb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IINN","BK4082","ICCM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508147706","title":"Icecure Medical Ltd.盘中异动 早盘股价大涨5.20%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508147706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508147706?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:53","pubTimestamp":1738597989,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时53分，Icecure Medical Ltd.股票出现异动，股价快速上涨5.20%。截至发稿，该股报1.32美元/股，成交量7.5639万股，换手率0.13%，振幅5.20%。Icecure Medical Ltd.股票所在的医疗器械行业中，整体跌幅为0.20%。Icecure Medical Ltd.公司简介：Icecure Medical Ltd是一家商业化的医疗器械公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203235309abc118f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203235309abc118f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505117870","title":"Icecure Medical Ltd.盘中异动 早盘大幅拉升5.08%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505117870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505117870?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:32","pubTimestamp":1737642736,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时32分，Icecure Medical Ltd.股票出现异动，股价急速拉升5.08%。截至发稿，该股报1.24美元/股，成交量1.431万股，换手率0.03%，振幅1.69%。Icecure Medical Ltd.股票所在的医疗器械行业中，整体涨幅为0.14%。其相关个股中，Beyond Air, Inc.、沃氪医疗、Naya Biosciences, Inc.涨幅较大，Helius Medical Technologies, Inc.、Vivos Therapeutics, Inc.、Ainos, Inc.较为活跃，换手率分别为4.44%、1.09%、0.83%，振幅较大的相关个股有Pacific Biosciences Of California, Inc.、Vivos Therapeutics, Inc.、Beyond Air, Inc.，振幅分别为8.28%、6.06%、5.78%。Icecure Medical Ltd.公司简介：Icecure Medical Ltd是一家商业化的医疗器械公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223217a22d0983&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223217a22d0983&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ICCM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505770326","title":"Icecure Medical Ltd.盘中异动 大幅下挫5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505770326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505770326?lang=zh_cn&edition=full","pubTime":"2025-01-23 03:39","pubTimestamp":1737574767,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日03时39分，Icecure Medical Ltd.股票出现波动，股价急速跳水5.67%。Icecure Medical Ltd.股票所在的医疗器械行业中，整体涨幅为0.04%。其相关个股中，Ainos Inc C/Wts 29/07/2027 、Icad Inc.、沃氪医疗涨幅较大，Helius Medical Technologies, Inc.、Spectral Ai, Inc.、Biomerica, Inc.较为活跃，换手率分别为145.03%、26.41%、22.68%，振幅较大的相关个股有Baird Medical Investment Hldgs Ltd C/Wts 01/10/2029 、Ainos Inc C/Wts 29/07/2027 、Dih Holdings Us Inc C/Wts 20/04/2028 ，振幅分别为47.79%、45.92%、30.21%。Icecure Medical Ltd.公司简介：Icecure Medical Ltd是一家商业化的医疗器械公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123033927960d2f3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123033927960d2f3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ICCM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.icecure-medical.com","stockEarnings":[{"period":"1week","weight":-0.0393},{"period":"1month","weight":-0.2971},{"period":"3month","weight":-0.496},{"period":"6month","weight":-0.8836},{"period":"1year","weight":-0.9302},{"period":"ytd","weight":-0.8798}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1499},{"period":"1year","weight":0.2011},{"period":"ytd","weight":0.1338}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"IceCure Medical Ltd.于2006年在以色列注册成立。该公司是一家商业阶段的医疗器械公司，专注于液氮或LN2治疗肿瘤的冷冻消融系统和技术的研究、开发和营销。他们专有的冷冻消融技术是手术干预的微创替代方案，适用于肿瘤，包括在乳房、肺、肾、骨骼和其他适应症中发现的肿瘤。他们在行业领先的商业冷冻消融产品是ProSense系统。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.006729},{"month":2,"riseRate":0.4,"avgChangeRate":-0.024554},{"month":3,"riseRate":0.4,"avgChangeRate":-0.136229},{"month":4,"riseRate":0.4,"avgChangeRate":0.00193},{"month":5,"riseRate":0,"avgChangeRate":-0.15964},{"month":6,"riseRate":0.2,"avgChangeRate":-0.121379},{"month":7,"riseRate":0.6,"avgChangeRate":-0.067373},{"month":8,"riseRate":0.2,"avgChangeRate":-0.080011},{"month":9,"riseRate":0,"avgChangeRate":-0.176601},{"month":10,"riseRate":0.4,"avgChangeRate":0.0455},{"month":11,"riseRate":0.6,"avgChangeRate":-0.016804},{"month":12,"riseRate":0.4,"avgChangeRate":0.06553}],"exchange":"NASDAQ","name":"IceCure Medical Ltd.","nameEN":"IceCure Medical Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IceCure Medical Ltd.(ICCM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供IceCure Medical Ltd.(ICCM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"IceCure Medical Ltd.,ICCM,IceCure Medical Ltd.股票,IceCure Medical Ltd.股票老虎,IceCure Medical Ltd.股票老虎国际,IceCure Medical Ltd.行情,IceCure Medical Ltd.股票行情,IceCure Medical Ltd.股价,IceCure Medical Ltd.股市,IceCure Medical Ltd.股票价格,IceCure Medical Ltd.股票交易,IceCure Medical Ltd.股票购买,IceCure Medical Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IceCure Medical Ltd.(ICCM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供IceCure Medical Ltd.(ICCM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}